
InVivo Therapeutics Holdings Corp is a biotechnology business based in the US. InVivo Therapeutics shares (NVIV) are listed on the NASDAQ and all prices are listed in US Dollars. InVivo Therapeutics employs 7 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in InVivo Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NVIV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

InVivo Therapeutics stock price (NASDAQ: NVIV)
Use our graph to track the performance of NVIV stocks over time.InVivo Therapeutics shares at a glance
Latest market close | $4.11 |
---|---|
52-week range | $3.50 - $23.19 |
50-day moving average | $4.95 |
200-day moving average | $10.45 |
Wall St. target price | $37.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-7.53 |
Buy InVivo Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy InVivo Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
InVivo Therapeutics price performance over time
Historical closes compared with the close of $4.105 from 2022-06-29
1 week (2022-06-23) | 2.63% |
---|---|
1 month (2022-06-01) | -23.84% |
3 months (2022-04-01) | 1,107.35% |
6 months (2021-12-31) | 792.39% |
1 year (2021-07-01) | 440.13% |
---|---|
2 years (2020-07-01) | 166.56% |
3 years (2019-07-01) | 433.12% |
5 years (2017-06-30) | 52.04% |
InVivo Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -27.96% |
Return on equity TTM | -50.33% |
Profit margin | 0% |
Book value | $11.32 |
Market capitalisation | $5.6 million |
TTM: trailing 12 months
InVivo Therapeutics share dividends
We're not expecting InVivo Therapeutics to pay a dividend over the next 12 months.
Have InVivo Therapeutics's shares ever split?
InVivo Therapeutics's shares were split on a 1:25 basis on 26 April 2022. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InVivo Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for InVivo Therapeutics shares which in turn could have impacted InVivo Therapeutics's share price.
InVivo Therapeutics share price volatility
Over the last 12 months, InVivo Therapeutics's shares have ranged in value from as little as $3.5 up to $23.1875. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InVivo Therapeutics's is 1.26. This would suggest that InVivo Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
InVivo Therapeutics overview
InVivo Therapeutics Holdings Corp. , a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. .
Frequently asked questions
What percentage of InVivo Therapeutics is owned by insiders or institutions?Currently 0.044% of InVivo Therapeutics shares are held by insiders and 11.561% by institutions. How many people work for InVivo Therapeutics?
Latest data suggests 7 work at InVivo Therapeutics. When does the fiscal year end for InVivo Therapeutics?
InVivo Therapeutics's fiscal year ends in December. Where is InVivo Therapeutics based?
InVivo Therapeutics's address is: One Kendall Square, Cambridge, MA, United States, 02139 What is InVivo Therapeutics's ISIN number?
InVivo Therapeutics's international securities identification number is: US46186M6057 What is InVivo Therapeutics's CUSIP number?
InVivo Therapeutics's Committee on Uniform Securities Identification Procedures number is: 46186M100
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert